Vivakor’s Management Sees New Opportunities in Stem Cell Research
CORALVILLE, IA–(Marketwire – December 21, 2009) – Vivakor, Inc. ( OTCBB : VIVK ) — With the recent authorization of 13 new stem lines by the National Institutes of Health and another 96 new lines awaiting federal approval, combined with the Obama administration’s focus on funding research on these newly released stem cell lines (31 grants worth approximately $21 million have already been …
[Read the full article here]Related News:
Yale Stem Cell Researchers Awarded $4 Million In State Grants
Stem cell panel awards $10.4 million for research
First New Embryonic Stem Cell Lines Approved for U.S. Funding